Lactobacillus sp as a Probiotic for the Prevention of Clostridium difficile Associated Diarrhea
Downloads
Background: Antibiotic treatment can disturb the resistance of the gastrointestinal flora to colonization. This may result in complications, the most serious of which is Clostridium difficile associated diarrhea (CDAD). The aim of this study was to determine the effectiveness of probiotics for the prevention of CDAD.
Method: The databases used were Scopus, Proquest, CINAHL, Medline, Pubmed and ScienceDirect, limited to having been published in the last 5 years. A literature review followed the keyword search. The keywords used were probiotics, Clostridium difficile, associated, diarrhea, randomized, control and trial using "AND" and "OR”. Twelve trials with 5102 participants were included. Eight trials reported a preventive effect for CDAD using a mixture of 2 strains of lactobacillus, a mixture of 4 combination strains, a mixture of lactobacillus and Saccharomyces or a mixture of Biï¬dobacterium, Lactobacillus and Saccharomyces.
Result: Our findings indicate that probiotics may prevent CDAD. Most probiotics contain a singular strain. The combination with lactobacillus sp was the most effective at preventing CDAD.
Conclusion: In addition, 6 out of 8 trials had an in relation to preventing CDAD containing lactobacillus sp. Four studies said that there were some factors that meant that the probiotic could not reduce or prevent the CDAD.
Alberda, C., Marcushamer, S., Hewer, T., Journault, N., & Demetrios Kutsogiannis. (2018). Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile. https://doi.org/10.3390/nu10050539
Allen, S. J., Wareham, K., Wang, D., Bradley, C., Hutchings, H., Harris, W., ... Mack, D. (2013). Lactobacilli and bifi dobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium diffi cile diarrhoea in older inpatients ( PLACIDE ): a randomised , double-blind , placebo-controlled , multicentre trial. The Lancet, 6736(Cdd), 1–9. https://doi.org/10.1016/S0140-6736(13)61218-0
Approach, E. (2017). Clinical update. 13(4), 238–241.
Barker, A. K., Duster, M., Valentine, S., Hess, T., Archbald-pannone, L., & Guerrant, R. (2017). A randomized controlled trial of probiotics for Clostridium difficile infection in adults ( PICO ). (August), 3177–3180. https://doi.org/10.1093/jac/dkx254
Box, M. J., Ortwine, K. N., & Goicoechea, M. (2016). No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients : A Real-world Experience. (Table 1), 9–11. https://doi.org/10.1093/ofid/ofy192
Chatterjee, S., Kar, P., Das, T., Ray, S., Ganguly, S., Rajendiran, C., & Mitra, M. (2013). Randomised Placebo-controlled Double Blind Multicentric Trial on Efficacy and Safety of Lactobacillus acidophilus LA-5 ® and Bifidobacterium BB-12 ® for Prevention of Antibiotic-Associated Diarrhoea. 61(october), 708–712.
Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., ... Lohse, A. W. (2016). Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Tria. 1–7. https://doi.org/10.1093/ofid/ofw011
Evans, M., Salewski, R. P., Christman, M. C., Girard, S., & Tompkins, T. A. (2016). Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults : a randomised , double-blind , placebo-controlled trial. 94–103. https://doi.org/10.1017/S0007114516001665
Guandalini, S. (2011). Probiotics for Prevention and Treatment of Diarrhea. 45(December), 149–153.
Johnston, B. C., Stephanie S.Y. Ma, M., Z, J., Goldenberg, Bs., Kristian Thorlund, P., Per O. Vandvik, MD, P., ... Gordon H. Guyatt, M. (2013). Review Annals of Internal Medicine Probiotics for the Prevention of Clostridium difficile – Associated. (20).
Kabbani, T. A., Pallav, K., Dowd, S. E., Villafuerte-galvez, J., Vanga, R. R., Castillo, N. E., ... Kelly, C. P. (2017). Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. 0976. https://doi.org/10.1080/19490976.2016.1267890
Li, N., Zheng, B., Cai, H., Chen, Y., Qiu, M., Liu, M., ... M-b, L. (2018). Accepted Manuscript. https://doi.org/10.1016/j.jhin.2018.04.013
Mallina, R., Frcs, J. C., Frcs, N. B., Ahluwalia, V., Frcp, J. C., & Frcs, A. G. C. (2018). Journal of Infection and Public Health Probiotic containing Lactobacillus casei , Lactobacillus bulgaricus , and Streptococcus thermophiles ( ACTIMEL ) for the prevention of Clostridium difficile associated diarrhoea in the elderly with proximal femur fractures. Journal of Infection and Public Health, 11(1), 85–88. https://doi.org/10.1016/j.jiph.2017.04.001
Mizui, T., Teramachi, H., Tachi, T., Tamura, K., Shiga, H., Komada, N., ... Aoyama, S. (2013). Risk factors for Clostridium difficile -associated diarrhea and the effectiveness of prophylactic probiotic therapy. 68. https://doi.org/10.1691/ph.2013.3552
Ouwehand, A. C., Donglian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T., & Miller, L. E. (2014). Probiotics reduce symptoms of antibiotic use in a hospital setting : A randomized dose response study. Vaccine, 32(4), 458–463. https://doi.org/10.1016/j.vaccine.2013.11.053
Patel, U. C., Wieczorkiewicz, J. T., & Tuazon, J. (2016). Journal of Clinical Gerontology & Geriatrics Evaluation of advanced age as a risk factor for severe Clostridium dif fi cile infection. Journal of Clinical Gerontology & Geriatics, 7(1), 12–16. https://doi.org/10.1016/j.jcgg.2015.06.003
Selinger, C. P., Bell, A., Cairns, A., Lockett, M., Sebastian, S., & Haslam, N. (2013). Probiotic VSL # 3 prevents antibiotic-associated diarrhoea in a double-blind , randomized , placebo- controlled clinical trial. Journal of Hospital Infection, 84(2), 159–165. https://doi.org/10.1016/j.jhin.2013.02.019
Shan, L., Hou, P., Wang, Z., Liu, F., Chen, N., Shu, L., ... Shang, Y. (2013). Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. 4(December), 329–334. https://doi.org/10.3920/BM2013.0008
Sinclair, A., Xie, X., Saab, L., & Dendukuri, N. (2016). Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis. 4(4), 706–714. https://doi.org/10.9778/cmajo.20160087
Squellati, R. (2018). E v i d e n c e - B a s e d Pr a c t i c e i n t he Tre atm en t f o r Antibiotic-Associated Diarrhea in the I ntensive Care Unit. 30, 87–99. https://doi.org/10.1016/j.cnc.2017.10.008
Wong, S., Jamous, A., Driscoll, J. O., Sekhar, R., Weldon, M., Yau, C. Y., ... Forbes, A. (2014). A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries : a randomised controlled trial British Journal of Nutrition. 672–678. https://doi.org/10.1017/S0007114513002973
Xie, C., Li, J., Wang, K., Li, Q., & Chen, D. (2015). ScienceDirect Probiotics for the prevention of antibiotic- associated diarrhoea in older patients : A systematic review. Travel Medicine and Infectious Disease, 1–7. https://doi.org/10.1016/j.tmaid.2015.03.001
Zhang, Y., Li, L., Guo, C., Mu, D., Feng, B., Zuo, X., & Li, Y. (2016). Effects of probiotic type , dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria : a. BMC Gastroenterology, 1–11. https://doi.org/10.1186/s12876-016-0470-z
Authors who publish with Jurnal Ners agree to the following terms:
- Authors transfer the Copyright and grant Jurnal Ners the right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to remix, adapt and build upon the work with an acknowledgment of the work's authorship and of the initial publication in Jurnal Ners.
- Authors are permitted to copy and redistribute the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Ners.
Jurnal Ners requires a formal written declaration and transfer of copyright from the author(s) for each article published. We, therefore, ask you to complete and return this form, retaining a copy for your own records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication. The form can be downloaded HERE.
